Thomas W. Beetham
CIK 1741382 · Chief Operating Officer · last filed 2026-03-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$15.79M
Companies
3
Total Filings
26
Lifetime Open-Market Net
-$2.03M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VRDN | Chief Operating Officer | 13,361 | $16.35 | $218.5K | $117.0K | 5 | 2026-03-09 |
| Dianthus Therapeutics, Inc. /DE/ (MGTA) Delisted | See Remarks | 19,897 | $11.19 | $222.7K | -$41.1K | 8 | 2022-12-02 |
| KNSA | EVP & Chief Legal Officer | 300,000 | $51.89 | $15.57M | -$2.11M | 13 | 2021-03-23 |
Recent Filings · Page 3 of 3
26 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-03-17 | KNSA | Grant (A) | — | $0 | EDGAR |
| 2020-02-19 | KNSA | Sell (S) | −59 | -$1.1K | EDGAR |
| 2019-09-19 | KNSA | Grant (A) | — | $0 | EDGAR |
| 2019-03-06 | KNSA | Grant (A) | — | $0 | EDGAR |
| 2018-09-24 | KNSA | Grant (A) | — | $0 | EDGAR |
| 2018-05-29 | KNSA | Mixed | +6,392 | $0 | EDGAR |
Showing 21–26 of 26
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.